Search

A recent study published in the medical journal Neurology suggests that following the MIND diet, which combines elements of the Mediterranean and DASH diets, may lower the risk of cognitive impairment later in life. The study involved over 14,000 participants and found that those who closely adhered to the MIND diet had a 4% decreased risk of cognitive impairment compared to those who did not. The diet emphasizes green leafy vegetables, whole grains, olive oil, poultry, fish, beans, nuts, and berries, while limiting red meat, fast food, and sweets. However, it is important to note that these findings only show an association and do not prove that the MIND diet prevents cognitive impairment. Further research is needed to explore the impact of the diet on different populations and genders. [Extracted from the article]

A new study published in the medical journal Neurology has found no link between migraine and the risk of developing Parkinson's disease in female participants. The study followed 39,312 female participants with an average age of 55 for an average of 22 years. After adjusting for other factors, researchers found that people with migraine were no more likely to develop Parkinson's disease than those without migraine. However, the study only involved female health professionals who were primarily white, so further research is needed to determine if the results apply to other groups. [Extracted from the article]

A study published in the medical journal Neurology has found that consuming more ultra-processed foods, such as soft drinks, chips, and cookies, is associated with a higher risk of cognitive decline and stroke. However, the study does not prove that these foods directly cause these health issues, only that there is an association. Ultra-processed foods are high in added sugar, fat, and salt, and low in protein and fiber. The study also found that the association between ultra-processed foods and stroke was greater among Black participants. Further research is needed to understand the specific components of these foods that contribute to these effects. [Extracted from the article]

A recent study published in the medical journal Neurology examined the factors that lead older adults to stop driving. The study involved 283 participants with an average age of 72 who drove at least once a week. The researchers found that female participants, people who developed cognitive impairment, and people who performed worse on cognitive tests were more likely to stop driving. However, the amount of biomarkers for Alzheimer's disease in the brain and spinal fluid did not predict stopping driving. The study supports the recommendations of the American Academy of Neurology's 2010 guideline that individuals with mild cognitive impairment should be counseled to no longer drive. [Extracted from the article]

A preliminary study presented at the American Academy of Neurology's 76th Annual Meeting suggests that pesticides and herbicides used in farming may be linked to Parkinson's disease in the Rocky Mountain and Great Plains region of the United States. The study analyzed Medicare records from 2009 and found that the pesticides simazine, atrazine, and lindane had the strongest relationship with Parkinson's disease. People living in counties with the highest exposure to simazine were 36% more likely to have Parkinson's disease compared to those with the lowest exposure. The study highlights the need for further research to understand the relationship between pesticides and Parkinson's disease and to reduce the risk of the disease by lowering pesticide levels. [Extracted from the article]

A recent study published in the medical journal Neurology suggests that for individuals with drug-resistant epilepsy, having a trained seizure dog companion may help reduce the frequency of seizures. The study followed 25 adults with severe epilepsy who had not responded to traditional treatments. Participants reported an average of 31% fewer seizures when partnered with a seizure dog, with some experiencing a 50-100% reduction. However, the study also noted that not everyone may benefit from this partnership, and further research is needed to determine who can benefit most from working with seizure dogs. [Extracted from the article]

Press registration is now open for the 76th Annual Meeting of the American Academy of Neurology (AAN), which will be held from April 13-18, 2024. The meeting will feature the latest advances in neurologic research, with over 2,600 abstracts covering 27 neurology specialties. It will also include late-breaking research, key lectures, and educational courses. Journalists can attend the meeting in person in Denver or participate online. Press registration is required and the deadline is April 5, 2024. The AAN is the world's largest association of neurologists and is dedicated to promoting high-quality patient-centered neurologic care. [Extracted from the article]

A study published in the medical journal Neurology has found that Black people who consume more whole grains, such as breads, cereals, quinoa, and popcorn, may experience a slower rate of memory decline compared to those who consume fewer whole grain foods. The study, which followed 3,326 participants without dementia for an average of six years, found that Black individuals who consumed the most whole grains had lower levels of memory decline, equivalent to being 8.5 years younger than those who consumed small amounts of whole grains. However, the study only shows an association and does not prove that eating more whole grains directly slows memory decline. Further research is needed to validate these findings and explore the effects of whole grains on cognition in different racial groups. [Extracted from the article]

A study published in the medical journal Neurology has found that individuals with low education and income levels may have a 10% increased risk of death or dependency on others after a stroke compared to those with higher education and income levels. The study, conducted in Sweden, does not prove that low education and income cause worse outcomes after a stroke, but it does show an association. The researchers suggest that interventions to reduce disparities could potentially save lives. However, the study has limitations, such as incomplete information on medical care received and other social determinants of health. [Extracted from the article]

Keywords: American Academy of Neurology; Autoimmune Diseases and Conditions; Autoimmune Diseases and Conditions of the Nervous System; CNS Demyelinating Autoimmune Disease; Demyelinating Diseases and Conditions; Health and Medicine; Immune System Diseases and Conditions; Multiple Sclerosis; Neuroimmunology; Neurology; Risk and Prevention EN American Academy of Neurology Autoimmune Diseases and Conditions Autoimmune Diseases and Conditions of the Nervous System CNS Demyelinating Autoimmune Disease Demyelinating Diseases and Conditions Health and Medicine Immune System Diseases and Conditions Multiple Sclerosis Neuroimmunology Neurology Risk and Prevention 1461 1461 1 05/02/23 20230505 NES 230505 2023 MAY 5 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, MINNEAPOLIS - A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease. Called radiologically isolated syndrome, the condition is diagnosed in people who do not have MS symptoms but who have abnormalities in the brain or spinal cord called lesions, similar to those seen in MS. [Extracted from the article]

Those in the combined biofeedback and exercise group experienced a two times greater reduction in symptom severity compared to people in the exercise group, as well as a 1.3 times greater reduction in symptom severity compared to people in the biofeedback group. Exercise, breathing practice may improve symptoms Similarly, the combined group experienced a 1.2 times greater reduction in symptoms of depression compared to the exercise group, and 1.3 times greater reduction than the biofeedback group. [Extracted from the article]